Academic Journal
Docetaxel (D) with androgen suppression (AS) for high-risk localized prostate cancer (HrPC) patients (pts) who relapsed PSA after radical prostatectomy (RP) and/or radiotherapy (RT): A randomized phase III trial
| العنوان: | Docetaxel (D) with androgen suppression (AS) for high-risk localized prostate cancer (HrPC) patients (pts) who relapsed PSA after radical prostatectomy (RP) and/or radiotherapy (RT): A randomized phase III trial |
|---|---|
| المؤلفون: | Oudard, S., Latorzeff, I., Caty, A., Miglianico, L., Sevin, E., Hardy Bessard, A-C., Delva, R., Rolland, F., Chevreau, C., Priou, F., Beuzeboc, P., Gravis, G., Linassier, C., Gomez, P., Voog, E., Chinet, P., Muracciole, X., Abraham Jaillon, C., Elaidi, R., Culine, S. |
| المصدر: | Annals of Oncology ; volume 28, page v269-v270 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2017 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1093/annonc/mdx370.001 |
| الاتاحة: | http://dx.doi.org/10.1093/annonc/mdx370.001 https://api.elsevier.com/content/article/PII:S0923753420380595?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S0923753420380595?httpAccept=text/plain http://academic.oup.com/annonc/article-pdf/28/suppl_5/mdx370.001/19939528/mdx370.001.pdf |
| Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/ |
| رقم الانضمام: | edsbas.B0D84E16 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1093/annonc/mdx370.001 |
|---|